Inverse relation between prostate-specific antigen and insulin-like growth factor-binding protein 3 in bone metastases and serum of patients with prostate cancer
- PMID: 10636379
- DOI: 10.1016/S0140-6736(99)04805-9
Inverse relation between prostate-specific antigen and insulin-like growth factor-binding protein 3 in bone metastases and serum of patients with prostate cancer
Abstract
The usual osteoblastic phenotype of metastatic prostate cancer is unexplained. Here we show that tissue and serum concentrations of prostate-specific antigen (PSA)-vary inversely with a substrate protein that binds a growth factor known to activate osteoblasts. These findings suggest that PSA may contribute to the osteoblastic phenotype, and could thus represent a new drug target devoid of antiandrogenic toxicity.
Comment in
-
Regulatory mechanisms in prostate cancer.Lancet. 2000 Mar 25;355(9209):1100-1. doi: 10.1016/S0140-6736(05)72223-6. Lancet. 2000. PMID: 10744117 No abstract available.
-
Prostate cancer screening.Lancet. 2001 Apr 14;357(9263):1202. doi: 10.1016/S0140-6736(00)04343-9. Lancet. 2001. PMID: 11379564 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
